Diana Lee
Moderna Therapeutics (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Lung Cancer Treatments and Mutations, Melanoma and MAPK Pathways, Animal Virus Infections Studies, Synthesis and biological activity
Most-Cited Works
- → A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations(2010)2,690 cited
- → Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma(2008)503 cited
- → Planar cell polarity signalling couples cell division and morphogenesis during neurulation(2006)409 cited
- → Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling(2007)358 cited
- → A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes(2006)230 cited
- → Genetic Analysis of Female Gametophyte Development and Function(1998)197 cited
- → Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice(2022)181 cited
- → Differential Gene Expression Analysis Reveals Generation of an Autocrine Loop by a Mutant Epidermal Growth Factor Receptor in Glioma Cells(2006)166 cited
- → Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers(2011)160 cited
- → The Arabidopsis thaliana 4-coumarate:CoA ligase (4CL) gene: stress and developmentally regulated expression and nucleotide sequence of its cDNA(1995)150 cited